Complex monogenic disease detection and blocking method
Through nanopore methylation sequencing methods, sample gDNA is extracted and repaired and combined ligated, and a library is constructed for sequencing, and pathogenic mutations and methylation information is obtained, which solves the problem of diagnosis and blocking of complex single-gene diseases and achieves efficient diagnosis and blocking effects.
Patent Information
- Application Number
- CN202411848875.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-16
- Publication Date
- 2025-03-28
AI Technical Summary
The prior art is difficult to effectively diagnose and block complex monogenetic diseases, especially due to read length limitations and technical limitations, and traditional methods are difficult to identify methylation information of complex mutation types and gene regions.
Using nanopore methylation sequencing methods, the whole genome or targeted sequencing is achieved by extracting sample gDNA, end repair and A, combining ligands with linkers, library construction and nanopore sequencing, and obtaining pathogenic mutations and methylation information to assist in the construction of haplotypes to achieve diagnosis and blockade.
This method can effectively improve the detection rate of pathogenic mutations of complex single-gene diseases, directly detect nucleic acid methylation modification information, provide more comprehensive and fidelity methylation site information, assist in the construction of haplotypes, and achieve accurate diagnosis and blockade of complex single-gene diseases.